Latest Stock Split Details
Key information about Merrimack Pharmaceuticals, Inc.'s most recent stock split
Split Date: 2019-09-06
Split Ratio: 1271:1000
Price Before Split: $7.09
Price After Split: $5.58
Impact of the Stock Split
Understanding what this means for shareholders
- The total value of your investment remains the same
- You now own 1.27 times more shares (a 1271:1000 ratio)
- The price per share is reduced proportionally
Historical Stock Splits
A comprehensive history of Merrimack Pharmaceuticals, Inc.'s stock splits
| Date | Ratio | Is Reverse Split | Price Before Split | Price After Split |
|---|---|---|---|---|
| 2019-09-06 | 1271:1000 | No | $7.09 | $5.58 |
| 2017-09-06 | 1:10 | Yes | $0.73 | $0.07 |
About Merrimack Pharmaceuticals, Inc.
Company overview and industry information
Merrimack Pharmaceuticals, Inc. (MACK) operates in the Biotechnology industry. The recent 1271-for-1000 stock split reflects the company's growth and strategy to make shares more accessible to a broader range of investors.
Biotechnology
Go to Merrimack Pharmaceuticals, Inc. Summary